Grace Therapeutics, Inc. (GRCE:NASDAQ) closed at $1.93 on October 23, 2026, up 0.78% on the day. The stock trades 62.7% below its 52-week high of $5.18 and 7.8% above its 52-week low of $1.79. Over the past year, it lost 38.5%. Grace Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, GRCE closed higher on 117 days (46%). Its best day was April 14, 2026 (+12.04%) and its worst was April 23, 2026 (-45.48%). The stock moved 10% or more in a single session 4 times.
Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all which could help to increase treatment compliance and improve patient outcomes.
Find more stocks like GRCE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.